BMS, bluebird bio CAR-T therapy may see US approval by early 2021
Bristol Myers Squibb (BMS) and bluebird bio say the FDA has accepted their application on their multiple myeloma CAR-T cell therapy, ide-cel.
Archives for September 24, 2020
AZ vaccine study still on hold in the US, lawmakers hear majority of Americans remain susceptible to COVID-19
AstraZeneca's phase 3 COVID-19 vaccine trial remains on hold in the US as the FDA probe into a patient illness in the UK trial that initiated the global pause continues, the US Department of Health and Human Services Secretary, Alex Azar, told US media...